
    
      In this study, the investigators are going to examine the efficacy of vortioxetine
      augmentation in bipolar disorder patients with depressive symptoms.

      The study design is a double-blinded 6-week prospective study. It would be useful for
      clinicians because it will provide new evidence for the effect of vortioxetine in bipolar
      disorder patients with depressive symptoms.
    
  